Literature DB >> 28543967

Central nervous system involvement of primary cutaneous diffuse large B-cell lymphoma, leg type: 13 cases.

E Gardette1, A Maraval2, F Brunet-Possenti3,4, G Quereux4,5, H Beltraminelli4,6, I Templier4,7, J Hodel2, E Scherman8, E Durot9, M Bagot4,10, A Pham-Ledard11, F Grange4,12, M Beylot-Barry4,11, S Ingen-Housz-Oro1,4.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28543967     DOI： 10.1111/jdv.14358

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

Review 1.  Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.

Authors:  Amanda Krenitsky; Skylar Klager; Leigh Hatch; Carlos Sarriera-Lazaro; Pei Ling Chen; Lucia Seminario-Vidal
Journal:  Am J Clin Dermatol       Date:  2022-07-19       Impact factor: 6.233

Review 2.  Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Authors:  Thomas A Ollila; Adam J Olszewski
Journal:  Curr Treat Options Oncol       Date:  2018-06-21

3.  Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma.

Authors:  Thomas A Ollila; Habibe Kurt; Jozal Waroich; John Vatkevich; Ashlee Sturtevant; Nimesh R Patel; Patrycja M Dubielecka; Diana O Treaba; Adam J Olszewski
Journal:  Blood       Date:  2021-02-25       Impact factor: 22.113

4.  Leptomeningeal relapse in primary cutaneous DLBCL: Implications for a prophylactic CNS therapy.

Authors:  Deepak Sundriyal; Lima Arya; Ruchi Srivastava; Meenu Walia; Amit Sehrawat
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.